TickerFactsScreenerDevelopers

Corbus Pharmaceuticals Holdings, Inc. (CRBP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $542.5K2013: $303.0K2014: $6.26M2015: $12.34M2016: $14.99M2017: $62.54M2018: $41.75M2019: $31.75M2020: $85.43M2021: $25.01M2022: $17.00M2023: $13.72M2024: $17.20M2025: $28.49M$28.49M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$28.49M+65.7%
2024$17.20M+25.3%
2023$13.72M-19.3%
2022$17.00M-32.0%
2021$25.01M-70.7%
2020$85.43M+169.1%
2019$31.75M-24.0%
2018$41.75M-33.2%
2017$62.54M+317.1%
2016$14.99M+21.5%
2015$12.34M+97.0%
2014$6.26M+1966.7%
2013$303.0K-44.1%
2012$542.5K—